New Market Study, "GILUPI Nanomedizin - Product Pipeline Analysis, 2013 Update", Has Been Published
GILUPI Nanomedizin (GILUPI) is a medical device company. The company develops and commercializes medical devices for isolating rare cells from blood for diagnosis. The company develops a new medical detector, which is used in-vivo in a patient's vein for catching rare cells such as tumor cells or fetal cells. GILUPI's products finds application in diagnosing lung cancer, breast cancer, prostate cancer and prenatal diagnosis. The company has developed CellCollector for the in vivo isolation of circulating tumor cells. Its patented...
View full press release